AIRLINK 180.49 Increased By ▲ 0.13 (0.07%)
BOP 11.06 Decreased By ▼ -0.11 (-0.98%)
CNERGY 8.53 No Change ▼ 0.00 (0%)
CPHL 98.17 Decreased By ▼ -2.24 (-2.23%)
FCCL 45.89 Decreased By ▼ -0.07 (-0.15%)
FFL 16.12 Increased By ▲ 0.31 (1.96%)
FLYNG 27.85 Decreased By ▼ -0.04 (-0.14%)
HUBC 141.79 Decreased By ▼ -0.68 (-0.48%)
HUMNL 13.04 Increased By ▲ 0.03 (0.23%)
KEL 4.52 No Change ▼ 0.00 (0%)
KOSM 5.89 Increased By ▲ 0.05 (0.86%)
MLCF 61.90 No Change ▼ 0.00 (0%)
OGDC 212.20 Decreased By ▼ -2.12 (-0.99%)
PACE 5.91 Decreased By ▼ -0.01 (-0.17%)
PAEL 46.24 Decreased By ▼ -0.59 (-1.26%)
PIAHCLA 17.70 Decreased By ▼ -0.14 (-0.78%)
PIBTL 10.67 Increased By ▲ 0.05 (0.47%)
POWER 12.13 Decreased By ▼ -0.04 (-0.33%)
PPL 170.26 Decreased By ▼ -2.45 (-1.42%)
PRL 35.48 Decreased By ▼ -0.54 (-1.5%)
PTC 23.13 Decreased By ▼ -0.13 (-0.56%)
SEARL 95.40 Decreased By ▼ -0.66 (-0.69%)
SSGC 40.50 Decreased By ▼ -0.84 (-2.03%)
SYM 14.28 Decreased By ▼ -0.16 (-1.11%)
TELE 7.45 Increased By ▲ 0.07 (0.95%)
TPLP 10.38 Increased By ▲ 0.30 (2.98%)
TRG 67.60 Decreased By ▼ -0.30 (-0.44%)
WAVESAPP 10.00 No Change ▼ 0.00 (0%)
WTL 1.33 Decreased By ▼ -0.01 (-0.75%)
YOUW 3.85 Increased By ▲ 0.04 (1.05%)
AIRLINK 180.49 Increased By ▲ 0.13 (0.07%)
BOP 11.06 Decreased By ▼ -0.11 (-0.98%)
CNERGY 8.53 No Change ▼ 0.00 (0%)
CPHL 98.17 Decreased By ▼ -2.24 (-2.23%)
FCCL 45.89 Decreased By ▼ -0.07 (-0.15%)
FFL 16.12 Increased By ▲ 0.31 (1.96%)
FLYNG 27.85 Decreased By ▼ -0.04 (-0.14%)
HUBC 141.79 Decreased By ▼ -0.68 (-0.48%)
HUMNL 13.04 Increased By ▲ 0.03 (0.23%)
KEL 4.52 No Change ▼ 0.00 (0%)
KOSM 5.89 Increased By ▲ 0.05 (0.86%)
MLCF 61.90 No Change ▼ 0.00 (0%)
OGDC 212.20 Decreased By ▼ -2.12 (-0.99%)
PACE 5.91 Decreased By ▼ -0.01 (-0.17%)
PAEL 46.24 Decreased By ▼ -0.59 (-1.26%)
PIAHCLA 17.70 Decreased By ▼ -0.14 (-0.78%)
PIBTL 10.67 Increased By ▲ 0.05 (0.47%)
POWER 12.13 Decreased By ▼ -0.04 (-0.33%)
PPL 170.26 Decreased By ▼ -2.45 (-1.42%)
PRL 35.48 Decreased By ▼ -0.54 (-1.5%)
PTC 23.13 Decreased By ▼ -0.13 (-0.56%)
SEARL 95.40 Decreased By ▼ -0.66 (-0.69%)
SSGC 40.50 Decreased By ▼ -0.84 (-2.03%)
SYM 14.28 Decreased By ▼ -0.16 (-1.11%)
TELE 7.45 Increased By ▲ 0.07 (0.95%)
TPLP 10.38 Increased By ▲ 0.30 (2.98%)
TRG 67.60 Decreased By ▼ -0.30 (-0.44%)
WAVESAPP 10.00 No Change ▼ 0.00 (0%)
WTL 1.33 Decreased By ▼ -0.01 (-0.75%)
YOUW 3.85 Increased By ▲ 0.04 (1.05%)
BR100 12,481 Decreased By -0.2 (-0%)
BR30 37,748 Decreased By -259.8 (-0.68%)
KSE100 116,805 Increased By 29.4 (0.03%)
KSE30 35,843 Decreased By -6.6 (-0.02%)

KARACHI: The Pakistan Chemists and Druggists Association (PCDA) strongly condemned the imposition of an 18% general sales tax (GST) on alternative medicines and demanded immediate withdrawal. The tax hike is expected to increase prices by 20-25%, making these medicines unaffordable for the middle class.

A delegation from PCDA, led by Ghulam Hashim Noorani and Abdul Samad Budhani, met with Fayyaz Magon, Senior Vice President of the Federation of Pakistan Chambers of Commerce and Industry (FPCCI), to express their concerns. They urged the PCDA to play a role in getting the GST revoked.

The delegation explained that alternative medicines, including herbal and homeopathic remedies, are used by the middle class and are not subsidized by the government. The GST imposition will not only increase prices but also harm importers, traders, and retailers, potentially disrupting the distribution system and leading to a nationwide shortage of medicines.

The PCDA demanded that the government either provide subsidies and concessions to the pharmaceutical sector or exempt alternative medicines from GST, additional taxes, and withholding tax for non-filers. They called for immediate amendments to the Finance Bill and the issuance of an SRO to exempt medicines regulated under the DRAP Act and Medical Device Act from taxes.

The association warned that if the taxes are not withdrawn, it will lead to a significant increase in prices, making medicines unaffordable for the common man, and ultimately harming the public health.

Copyright Business Recorder, 2024

Comments

Comments are closed.